Screener
Champions Oncology CSBR Q4 2025 earnings
Reported December 15, 2025 · After market close
Revenue$15.0MMiss by $1.4M
EPS$0.02Miss by $0.06
Revenue estimate$16.4M
EPS estimate$0.08
Next report
Sep 14, 2026 (In 2 weeks)Revenue estimate$15.0M
EPS estimate-$0.01
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Champions Oncology report Q4 2025 earnings?
- Champions Oncology (CSBR) reported Q4 2025 earnings on December 15, 2025 after market close.
- What were Champions Oncology's Q4 2025 revenue and EPS?
- Champions Oncology reported revenue of $15.0M and eps of $0.02 for Q4 2025.
- Did Champions Oncology beat estimates in Q4 2025?
- Revenue missed the consensus estimate of $16.4M by $1.4M. EPS missed the consensus estimate of $0.08 by $0.06.
- How did Champions Oncology's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 11.5% from $13.5M a year earlier and eps declined 60.0% from $0.05.
- Where can I find Champions Oncology's Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001628280-25-057020) and the 10-Q periodic report (0001628280-25-057082) directly on SEC EDGAR. The filing index links above go to sec.gov.
